Naito Yuji

2020 - 2023 口腔内細菌叢を標的とした新規機能性ディスペプシア治療薬開発に向けた基盤研究

2020 - 2023 ガス分子薬開発に向けたヘムオキシゲナーゼ/一酸化炭素による腸内環境調整作用の解明

2020 - 2023 Pathomechanism of cerebral small vessel disease due to intracolonal bactriome

2020 - 2023 Pathological study of cancer-related sarcopenia focusing on the Gut-muscle axis and development of new treatments

2020 - 2023 腸内環境と骨格筋代謝のコミュニケーションに着目した運動効果の実験的・疫学的検証

2017 - 2022 Changes in the gut microbiota acquired by exercise - Effects of detraining and retraining-

2019 - 2022 血清ペプチドバイオマーカーを用いた大腸がん早期発見の大規模前向き検証

2019 - 2022 腸内細菌叢からみた過敏性腸症候群の病態解明

2018 - 2021 Mucosa-associated microbiota and bacteriophage in the pathophysiology of irritable bowel syndrome (IBS)

2018 - 2021 環状ジヌクレオチドに対する免疫応答と腸管炎症制御メカニズムの解明

2018 - 2021 The effect of Wnt5a derived peptide to reduce intestinal inflammation

2017 - 2020 Analysis of endoscopic brush samples identified mucosa associated dysbiosis and the expression of tight junction protein in functional dyspepsia.

2017 - 2020 Development of new therapeutic strategies for cancer cachexia targeting gut microbiota

2017 - 2020 The effect of pyroglutamyl peptide on gut microbiota

2016 - 2020 機能性野菜を用いた腸内フローラ解析による生体恒常性維持効果の実証研究

2016 - 2019 The development of drug delivery system of carbon monoxide for inflammatory bowel disease

2017 - 2019 代謝・マイオカイン・腸バリアに着目した骨格筋と腸の臓器相関に関する体力科学的研究

2015 - 2018 Development of practical method for the diagnosis of infection and antibiotics susceptibility of H. pylori

2015 - 2018 The role of Wnt5a peptide to enhance colonic epithelial healing for the treatment of IBD

2016 - 2018 高速高精度な選択反応モニタリング定量的質量分析法による大腸癌先制医療の確立

2013 - 2016 The role of Heme oxygenate-1 and carbon monoxide in the intestinal inflammation

2012 - 2015 The examination about the usefulness of SLC38A9 as genetic biomarker to predict blood concentration of azathioprine.

2013 - 2015 マイオカインSPARCの機能性,分泌・作用機構および運動処方への応用に関する研究

2013 - 2015 Hsp27とSPARC蛋白質の同定・機能解析と大腸癌における意義解明

2011 - 2015 消化管機能分子と血清タンパク質の系統的解析による抗糖尿病機能性糖鎖の開発

2011 - 2013 PGC-1を標的とした加齢性筋代謝不全予防食品の開発

2011 - 2013 大腸がんの早期・精密化診断を実現するペプチドバイオマーカーの開発

2010 - 2012 Functional analysis of AIF molecule and developement of therapy of rheumatoid arthritis

2010 - 2012 The effect of carbon monoxide in the intestinal inflammation

2010 - 2012 メチルグリオキザール修飾Hsp27蛋白質の同定と大腸癌における意義解明

2009 - 2011 Development of hyperthermicimmunetherapy for cancer

2009 - 2011 Detection and measurement of transthyretin with oxidative modification as a biomarker for disease prevention

2009 - 2011 消化管機能分子と血清タンパク質の系統的解析による抗糖尿病機能性糖鎖の開発

2008 - 2009 腸管運動機能不全におけるc-Kit蛋白質の翻訳後修飾の同定とその分子機能解明

2006 - 2007 The invention of carbon monoxide inhalation system and the, utility of this system on the intestinal inflammau

2006 - 2007 Prediction of the cytotoxicity of additives in cosmetics on UV-exposed human skin keratinocytes

2006 - 2007 Hyperthermic treatment for early stage of rheumatoid arthritis

2005 - 2007 A study on the optimal predictive biomarkers for the effect of exercise-training on prevention of the lifestyle-related disease.

2005 - 2006 Cardioprotection with nuclear-targeted Akt/PKB

2004 - 2006 detection of marker groups indicating differentiating and regenerating stages of digestive cells using protein chips

2004 - 2005 Development of Hyperthermia Treatment for Early Stage of Rheumatoid Arthritis

2003 - 2004 Production of Oxidative Stress-Related ProteinChip and Its Evaluation on Biomarker for Common Disease

2002 - 2003 NF-κB as a therapeutic target in inflammatory bowel disease